In a prognostic analysis of all invasive breast cancers according to molecular subtype, FABP4 positivity (p = 0.023) and CPT-1 positivity (p = 0.027) were associated with a shorter DFS among triple negative breast cancers (TNBCs) (Figure 4). The gene discussed is FABP4; the disease is triple-negative breast carcinoma.